II. Indications
- FDA Approved
- Metastatic Islet Cell Cancer (Pancreas)
- Off-Label
- Adrenal cancer (metastatic)
- Carcinoid Tumor (metastatic)
III. Mechanism
- See Alkylating Agent
- Antineoplastic methyl-nitrosourea isolated from the bacterium Streptomyces achromogenes
- Alkylating Agent that cross-links DNA during all Cell Cycle phases and inhibts DNA synthesis
- Glucose sub-component allows for preferential uptake by pancreatic beta cells
IV. Medications
- Intravenous: 1 g vial
V. Dosing
- See other references for disease specific dosing protocols
VI. Adverse Effects
- Extravasation
- Skin necrosis
- Secondary Malignancy
- Nephrotoxicity
- Maximize hydration to prevent Renal Injury
- Hepatotoxicity
- Hypoglycemia
- Impaired future fertility
- Alopecia
-
Diabetes Mellitus
- Diabetes Mellitus may be induced with high dose Streptozocin
- Minimal myelosuppression
- Contrast with other nitrosurea Antineoplastic Agents
- However, may result in Anemia
VII. Safety
- Avoid in Lactation
- Avoid in pregnancy (contraindicated in all trimesters)
- Teratogenic and adverse outcomes
- Use reliable Contraception
- Monitoring
VIII. Resources
- Streptozocin (DailyMed)
- Streptozocin (Liver Tox)